Mobile therapeutic attention for treatment-resistant schizophrenia (m-RESIST): a prospective multicentre feasibility study protocol in patients and their caregivers

BMJ Open
Anna Alonso-SolísEva Grasa

Abstract

Treatment-resistant schizophrenia (TRS) is a severe form of schizophrenia. In the European Union, approximately 40% of people with schizophrenia have TRS. Factors such as the persistence of positive symptoms or higher risk of comorbidities leave clinicians with a complex scenario when treating these patients. Intervention strategies based on mHealth have demonstrated their ability to support and promote self-management-based strategies. Mobile therapeutic attention for treatment-resistant schizophrenia (m-RESIST), an innovative mHealth solution based on novel technology and offering high modular and flexible functioning, has been developed specifically for patients with TRS and their caregivers. As intervention in TRS is a challenge, it is necessary to perform a feasibility study before the cost-effectiveness testing stage. This manuscript describes the protocol for a prospective multicentre feasibility study in 45 patients with TRS and their caregivers who will be attended in the public health system of three localities: Hospital Santa Creu Sant Pau (Spain), Semmelweis University (Hungary) and Gertner Institute & Sheba Medical Center (Israel). The primary aim is to investigate the feasibility and acceptability of the m-RESIST ...Continue Reading

References

Jul 1, 1990·Schizophrenia Research·D AddingtonB Schissel
Jan 1, 1987·Schizophrenia Bulletin·S R KayL A Opler
Jun 1, 1993·The American Journal of Psychiatry·X F AmadorJ M Gorman
Jun 6, 1996·Health Policy·R Brooks
Dec 18, 2001·Biological Psychiatry·R R Conley, D L Kelly
May 21, 2003·Acta Psychiatrica Scandinavica. Supplementum·J M HaroUNKNOWN SOHO Study Group
Jun 11, 2004·Journal of Evaluation in Clinical Practice·Gillian A LancasterPaula R Williamson
Mar 3, 2005·The American Journal of Psychiatry·Nancy C AndreasenDaniel R Weinberger
Apr 15, 2005·Journal of Medical Internet Research·Gunther Eysenbach
Dec 25, 2007·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Helio Elkis, Herbert Y Meltzer
Nov 17, 2009·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Sunil KripalaniTerry A Jacobson
Jul 20, 2010·BMC Medical Research Methodology·Mubashir ArainGillian A Lancaster
Sep 8, 2011·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·H U WittchenH-C Steinhausen
Nov 16, 2011·Telemedicine Journal and E-health : the Official Journal of the American Telemedicine Association·Marie Pierre GagnonJosé Emparanza
Mar 29, 2012·The Ceylon Medical Journal·Jayamal de SilvaVaruni A de Silva
Jan 11, 2013·BMJ : British Medical Journal·An-Wen ChanDavid Moher
Sep 3, 2013·International Clinical Psychopharmacology·James L KennedyJohn C Hornberger
May 6, 2014·Journal of Psychiatric Research·A MillierN Cadi-Soussi
Nov 8, 2015·JMIR MHealth and UHealth·Joseph Firth, John Torous
Dec 24, 2015·Psychiatric Services : a Journal of the American Psychiatric Association·Dror Ben-ZeevTanzeem Choudhury
May 25, 2016·The Psychiatric Clinics of North America·Helio Elkis, Peter F Buckley
Mar 5, 2017·Revista de psiquiatrí́a y salud mental·Lucia BonetJulio Sanjuan

❮ Previous
Next ❯

Citations

May 7, 2020·NPJ Schizophrenia·Philip HensonJohn Torous
Oct 22, 2020·International Journal of Environmental Research and Public Health·Anna Alonso-SolísM-Resist Group

❮ Previous
Next ❯

Methods Mentioned

BETA
cognitive behavioural therapy

Software Mentioned

Atlas
ti
Qualtrics
RESIST

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.